Literature DB >> 32538860

Lower Extremity Muscle Involvement in the Intermediate and Bethlem Myopathy Forms of COL6-Related Dystrophy and Duchenne Muscular Dystrophy: A Cross-Sectional Study.

Abhinandan Batra1, Donovan J Lott1, Rebecca Willcocks1, Sean C Forbes1, William Triplett1, Jahannaz Dastgir2, Pomi Yun2, A Reghan Foley2, Carsten G Bönnemann2, Krista Vandenborne1, Glenn A Walter3.   

Abstract

Collagen VI-related dystrophies (COL6-RDs) and Duchenne muscular dystrophy (DMD) cause progressive muscle weakness and disability. COL6-RDs are caused by mutations in the COL6 genes (COL6A1, COL6A2 and COL6A3) encoding the extracellular matrix protein collagen VI, and DMD is caused by mutations in the DMD gene encoding the cytoplasmic protein dystrophin. Both COL6-RDs and DMD are characterized by infiltration of the muscles by fatty and fibrotic tissue. This study examined the effect of disease pathology on skeletal muscles in lower extremity muscles of COL6-RDs using timed functional tests, strength measures and qualitative/ quantitative magnetic resonance imaging/spectroscopy measures (MRI/MRS) in comparison to unaffected (control) individuals. Patients with COL6-RD were also compared to age and gender matched patients with DMD.Patients with COL6-RD presented with a typical pattern of fatty infiltration of the muscle giving rise to an apparent halo effect around the muscle, while patients with DMD had evidence of fatty infiltration throughout the muscle areas imaged. Quantitatively, fat fraction, and transverse relaxation time (T2) were elevated in both COL6-RD and DMD patients compared to unaffected (control) individuals. Patients with COL6-RD had widespread muscle atrophy, likely contributing to weakness. In contrast, patients with DMD revealed force deficits even in muscle groups with increased contractile areas.

Entities:  

Keywords:  Collagen VI-related dystrophies; duchenne muscular dystrophy; force production; magnetic zzm321990resonance imaging

Mesh:

Substances:

Year:  2020        PMID: 32538860      PMCID: PMC8603396          DOI: 10.3233/JND-190457

Source DB:  PubMed          Journal:  J Neuromuscul Dis


  43 in total

1.  MRI for the demonstration of subclinical muscle involvement in muscular dystrophy.

Authors:  S Sookhoo; I Mackinnon; K Bushby; P F Chinnery; D Birchall
Journal:  Clin Radiol       Date:  2007-02       Impact factor: 2.350

2.  Assessment of intramuscular lipid and metabolites of the lower leg using magnetic resonance spectroscopy in boys with Duchenne muscular dystrophy.

Authors:  Donovan J Lott; Sean C Forbes; Sunita Mathur; Sean A Germain; Claudia R Senesac; H Lee Sweeney; Glenn A Walter; Krista Vandenborne
Journal:  Neuromuscul Disord       Date:  2014-04-13       Impact factor: 4.296

3.  Chemical shift-based MRI to measure fat fractions in dystrophic skeletal muscle.

Authors:  William T Triplett; Celine Baligand; Sean C Forbes; Rebecca J Willcocks; Donovan J Lott; Soren DeVos; Jim Pollaro; William D Rooney; H Lee Sweeney; Carsten G Bönnemann; Dah-Jyuu Wang; Krista Vandenborne; Glenn A Walter
Journal:  Magn Reson Med       Date:  2013-09-04       Impact factor: 4.668

4.  Muscle fiber atrophy and regeneration coexist in collagen VI-deficient human muscle: role of calpain-3 and nuclear factor-κB signaling.

Authors:  Sonia Paco; Isidre Ferrer; Cristina Jou; Victoria Cusí; Joan Corbera; Ferran Torner; Francesca Gualandi; Patrizia Sabatelli; Anna Orozco; Anna Maria Gómez-Foix; Jaume Colomer; Andres Nascimento; Cecilia Jimenez-Mallebrera
Journal:  J Neuropathol Exp Neurol       Date:  2012-10       Impact factor: 3.685

5.  Lateral transmission of force is impaired in skeletal muscles of dystrophic mice and very old rats.

Authors:  Krishnan S Ramaswamy; Mark L Palmer; Jack H van der Meulen; Abigail Renoux; Tatiana Y Kostrominova; Daniel E Michele; John A Faulkner
Journal:  J Physiol       Date:  2011-01-10       Impact factor: 5.182

6.  Multicenter prospective longitudinal study of magnetic resonance biomarkers in a large duchenne muscular dystrophy cohort.

Authors:  Rebecca J Willcocks; William D Rooney; William T Triplett; Sean C Forbes; Donovan J Lott; Claudia R Senesac; Michael J Daniels; Dah-Jyuu Wang; Ann T Harrington; Gihan I Tennekoon; Barry S Russman; Erika L Finanger; Barry J Byrne; Richard S Finkel; Glenn A Walter; H Lee Sweeney; Krista Vandenborne
Journal:  Ann Neurol       Date:  2016-02-19       Impact factor: 10.422

Review 7.  A critical review of functional assessment tools for upper limbs in Duchenne muscular dystrophy.

Authors:  Elena S Mazzone; Gessica Vasco; Concetta Palermo; Flaviana Bianco; Carmen Galluccio; Valeria Ricotti; Antonella D Castronovo; Maria Sole D I Mauro; Marika Pane; Anna Mayhew; Eugenio Mercuri
Journal:  Dev Med Child Neurol       Date:  2012-06-19       Impact factor: 5.449

8.  Results of a two-year pilot study of clinical outcome measures in collagen VI- and laminin alpha2-related congenital muscular dystrophies.

Authors:  Katherine G Meilleur; Minal S Jain; Linda S Hynan; Ching-Yi Shieh; Eunice Kim; Melissa Waite; Michelle McGuire; Courtney Fiorini; Allan M Glanzman; Marion Main; Kristy Rose; Tina Duong; Roxanna Bendixen; Melody M Linton; Irene C Arveson; Carmel Nichols; Kelly Yang; Kenneth H Fischbeck; Kathryn R Wagner; Kathryn North; Ami Mankodi; Christopher Grunseich; Elizabeth J Hartnett; Michaele Smith; Sandra Donkervoort; Alice Schindler; Angela Kokkinis; Meganne Leach; A Reghan Foley; James Collins; Francesco Muntoni; Anne Rutkowski; Carsten G Bönnemann
Journal:  Neuromuscul Disord       Date:  2014-09-28       Impact factor: 4.296

9.  Reliability of the North Star Ambulatory Assessment in a multicentric setting.

Authors:  E S Mazzone; S Messina; G Vasco; M Main; M Eagle; A D'Amico; L Doglio; L Politano; F Cavallaro; S Frosini; L Bello; F Magri; A Corlatti; E Zucchini; B Brancalion; F Rossi; M Ferretti; M G Motta; M R Cecio; A Berardinelli; P Alfieri; T Mongini; A Pini; G Astrea; R Battini; G Comi; E Pegoraro; L Morandi; M Pane; C Angelini; C Bruno; M Villanova; G Vita; M A Donati; E Bertini; E Mercuri
Journal:  Neuromuscul Disord       Date:  2009-06-23       Impact factor: 4.296

10.  Characterization of pulmonary function in Duchenne Muscular Dystrophy.

Authors:  O H Mayer; R S Finkel; C Rummey; M J Benton; A M Glanzman; J Flickinger; B-M Lindström; T Meier
Journal:  Pediatr Pulmonol       Date:  2015-03-09
View more
  1 in total

1.  CRISPR/Cas9-Mediated Allele-Specific Disruption of a Dominant COL6A1 Pathogenic Variant Improves Collagen VI Network in Patient Fibroblasts.

Authors:  Arístides López-Márquez; Matías Morín; Sergio Fernández-Peñalver; Carmen Badosa; Alejandro Hernández-Delgado; Daniel Natera-de Benito; Carlos Ortez; Andrés Nascimento; Daniel Grinberg; Susanna Balcells; Mónica Roldán; Miguel Ángel Moreno-Pelayo; Cecilia Jiménez-Mallebrera
Journal:  Int J Mol Sci       Date:  2022-04-16       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.